For instance, downregulation of OGT protein levels under pharmacological inhibition of OGA has been demonstrated in a range of cell lines including those of cervical cancer, neuroblastoma, leukemia, colon cancer, and fibroblast origins [12,13,14,15]. This evidence concerns the gene OGT and malignant colon neoplasm.